Written by International Journal of Pharmacology and Clinical Sciences, 2024, 13, 1, 25-30.
DOI: 10.5530/ijpcs.2024.13.7
Published: November 2024
Type: Review Article
Authors: Yousef Ahmed Alomi*, Abeer Hussin Almasoudi, Mohammad Ghazzai Alharbi, Ruqayyah Mohammed AL Nasser, Taghreed Ahmed Alshammari, Noura Saleem Nazal Alonzi.
Author(s) affiliations:
Yousef Ahmed Alomi*,
BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor, and Data Analyst, Riyadh, SAUDI ARABIA.
Abeer Hussin Almasoudi,
BSc. Pharm, BCPS., Director, Organizational Excellence, Ministry of Health Branch, Tabuk, SAUDI ARABIA.
Mohammad Ghazzai Alharbi,
Bsc pharm, Albukayriyah General Hospital , Alqassim Health Cluster, SAUDI ARABIA.
Ruqayyah Mohammed AL Nasser,
Pharm D, Health Blessing Pharmaceutical, Jeddah, SAUDI ARABIA.
Taghreed Ahmed Alshammari,
Pharm Technician, King Fahad Specialist Hospital, Tabuk Health Cluster, SAUDI ARABIA.
Noura Saleem Nazal Alonzi,
Pharm Technician, Maternity & Child Hospital,Tabuk Health Cluster, SAUDI ARABIA.
Abstract
Objectives: This paper is dedicated to emphasizing the profound importance of the Clinical Compounding Services policy in Community pharmacy practice, a pioneering initiative in Saudi Arabia. Methods: This narrative review of community pharmacy policy and procedures for the clinical compounding services system was conducted meticulously. We conducted a comprehensive search across reputable databases, including PubMed, Medline, and Google Scholar, for specific Clinical Compounding and Services policies and procedures in Community pharmacy practice. The search period spans from the 1960s until October 2021, and the term is in English, encompassing narrative review, systemic review, Meta-analysis, and guidelines. All hospital or community Community pharmacy services are included in a search term. National and international guidelines for general clinical compounding services in hospital practice are also included. The Community Pharmacy Clinical Compounding and Services Committee, comprised of various expert members, formulated the guidelines of the policy draft, which were reviewed and corrected multiple times to ensure accuracy and reliability. The topic emphasizes Community Pharmacy Clinical Compounding and Services policy and procedures competency. Results: The competency of the Community Pharmacy Clinical Compounding and Services policy consisted of various items. That has included Clinical Compounding Services committee, patient assessment, ISMP self-assessment of Clinical Compounding n Services for ambulatory care and community pharmacy, the extemporaneous standards, stabilities the extemporaneous preparations, and compounding safety. The pharmaceutical calculations, medication errors reporting system, adverse drug reactions reporting system, drug quality-reporting system at different pharmaceutical care departments and units, and drug monitoring with all pediatrics or adults extemporaneous preparations products with various diseases. Conclusion: The Community Pharmacy Clinical Compounding and Services policy is a new initiative and a potential gamechanger in pharmacy practice. The policy, with its various standards and guidelines for all extemporaneous preparations, has the potential to benefit patients, depending on their condition-related diseases significantly. More than that, it is the initial step in future innovation, paving the way to manufacturing new investigational pharmaceutical products. Therefore, the competency of the Clinical Compounding Services policy is highly recommended for implementation in a community setting in Saudi Arabia, offering a promising future for pharmacy practice in the region.
Keywords: Clinical Compounding, Community, Competency, Pharmacy, Policy, Saudi Arabia, Services.